1. Home
  2. GHG vs ALDX Comparison

GHG vs ALDX Comparison

Compare GHG & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.03

Market Cap

101.9M

ML Signal

N/A

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

N/A

Current Price

$1.35

Market Cap

88.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GHG
ALDX
Founded
2004
2004
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.9M
88.1M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
GHG
ALDX
Price
$1.03
$1.35
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $6.60
AVG Volume (30 Days)
7.9K
★ 834.0K
Earning Date
08-24-2026
11-04-2026
Dividend Yield
★ 5.94%
N/A
EPS Growth
N/A
★ 40.43
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$56.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.76
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$1.07
52 Week High
$2.31
$5.93

Technical Indicators

Market Signals
Indicator
GHG
ALDX
Relative Strength Index (RSI) 36.28 39.82
Support Level $0.99 $1.07
Resistance Level $1.16 $1.58
Average True Range (ATR) 0.03 0.10
MACD 0.00 -0.01
Stochastic Oscillator 0.00 25.00

Price Performance

Historical Comparison
GHG
ALDX

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: